Screening of children

AIIMS Delhi starts screening of children for Covaxin trials

New Delhi: The screening of children for trial of Covaxin, India’s first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday. The trial…